MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from at the
market offering of...
$3,274K
Net cash provided by
financing activities
$3,274K
Net decrease in
cash, cash...
-$11,882K
Canceled cashflow
$3,274K
Stock-based compensation
expense
$1,233K
Non-cash interest
expense
$551K
Prepaid expenses and
other assets
-$457K
Depreciation expense
$402K
Non-cash lease expense
$198K
Net cash used in
operating activities
-$15,156K
Canceled cashflow
$2,841K
Net loss
-$16,370K
Accounts payable,
accrued expenses and...
-$1,205K
Operating lease liability
-$397K
Change in fair value of
derivative liability
$25K
Back
Back
Cash Flow
source: myfinsight.com
Werewolf Therapeutics, Inc. (HOWL)
Werewolf Therapeutics, Inc. (HOWL)